All Hepatitis C virus articles
-
News
‘Perfect storm’ of mutations drives infection-triggered autoimmune disease
Scientists have discovered how a hepatitis C infection causes autoimmune disease, disproving a long-standing theory and opening a promising new approach to developing treatments for autoimmune conditions.
-
News
New hope in the fight against Hepatitis C: Broadly effective innovative vaccine design
Epitope-focused immunogens in mouse models with a human antibody repertoire triggered a robust immune response in a new study. The produced antibodies were capable of successfully neutralizing multiple genetically diverse HCV strains.
-
News
Study probes disparities in hepatitis C care for reproductive-aged women to break cycle of viral transmission
Researchers and clinicians are working to minimize racial and ethnic disparities in hepatitis C testing and treatment for women with opioid use disorder and their children through innovative programs.
-
News
Madrid study shows decrease in active hepatitis C infection among risk groups
A study conducted through a mobile screening unit in Madrid, Spain from 2017 to 2023 found that active hepatitis C virus (HCV) infection decreased from 23% to 6% in that period among people who use drugs (PWUD) that visited the unit.
-
News
New study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV
A new study provides new perspectives on transmission of hepatitis C virus (HCV), a virus that infects the liver and can be transmitted during injection of drugs, among men who have sex with men (MSM).
-
News
WHO prequalifies the first self-test for hepatitis C virus
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
-
News
Hepatitis C leaves ‘scars’ in immune cells even after successful treatment
Researchers have discovered that traces of ‘epigenetic scars’ remain in regulatory T cells and exhibit sustained inflammatory properties long after the Hepatitis C virus is cleared from the body.